COLLATERAL EFFECTS IN WOMEN WITH BREAST CANCER PRESENTED BY PROTOCOL ANTHRACYCLINE, CYCLOPHOSPHAMIDE AND TAXANE (ACT) ASSOCIATED TO LIFE´S STYLE AND EMOTIONAL STATE: LITERATURE´S REVIEW
Andressa Janete da Silva, Ana Laura Remédio Zeni Beretta*
ABSTRACT
Breast cancer is the most common and worldwide incident type of cancer among women. From distrust to aftercare, deleterious effects impacts both psychological and physical health influencing directly in patient´s life quality. The diagnosis and premature treatment characterizes the best approach to extend this population´s lives. Therefore, processes such as self-examination, regular appointments with the gynecologist and examinations such as breast ultrasound and mammography are essential. "Anthracycline, Cyclophospamide and Taxane(ACT)" protocol used in women with breast cancer, is a therapy for the treatment of this type of cancer where medication and periodicity are used as follows: four cycles of "Doxorrubicin and Cyclophosphamide each 21 days, followed by 12 weeks of Paclitaxel.
This review is regarding the collateral effects presented by ACT protocol, in women with breast cancer, by using the specific literature available in the National Library of Medicine (PUBMED) and the Scientific Electronic Library Online (SCIELO). The data search in those platforms used a filter with the following words: breast cancer, chemotherapy, collateral effects and ACT protocol. Following this approach, 26 articles were selected. The results show that, in the presence of all symptoms presented by patients, it can be observed that in several articles the diagnosed women (in treatment or breast cancer survival) suffer many impacts from distinct natures: emotional, psychological, physical and hematological. These impacts result in the decrease in life quality of the patients.
Keywords: Breast cancer, chemotherapy, collateral effects and ACT protocol.
[Download Article]
[Download Certifiate]